Altered levels of exhaled Nitric Oxide in rheumatoid arthritis | All the latest summaries on the portal Medznat.ru. :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Altered levels of exhaled Nitric Oxide in rheumatoid arthritis

Altered levels of exhaled Nitric Oxide in rheumatoid arthritis Altered levels of exhaled Nitric Oxide in rheumatoid arthritis
Altered levels of exhaled Nitric Oxide in rheumatoid arthritis Altered levels of exhaled Nitric Oxide in rheumatoid arthritis

Rheumatoid arthritis (RA) is an autoimmune problem recognised by joint and bone disruption, but other organ systems can also be affected. 

See All

Key take away

Rheumatoid arthritis (RA) is an inflammatory disorder characterized by bone and joint destruction. It has been reported in previous studies that exhaled nitric oxide (NO) is a non-invasive marker of airway inflammation and has been found higher in many diseases. In the present study author compare the NO parameters between subjects with RA to healthy control subjects, and showed significant differences between subjects with RA and matched healthy control subjects regarding the exhaled NO parameters. 

Background

Rheumatoid arthritis (RA) is an autoimmune problem recognised by joint and bone disruption, but other organ systems can also be affected. According to the recent studies, RA may also affect the lungs. Exhaled nitric oxide (FENO) is considered as one of the markers of inflammation. The study compares the NO parameters within RA and healthy control subjects and assess whether the NO parameters associated with the functioning of lungs and disease activity among RA patients.

Method

Individuals were selected at the time of their routine outpatient visits to the rheumatology department. An algorithmic estimation of nitric oxide (NO) parameters (tissue concentration of NO in the airway wall (CawNO), alveolar NO concentration (CANO), and airway compartment diffusing capacity of NO (DawNO) were conducted. Controls involved the healthy participants who matched by gender, height and age. Median was used to represent the data. Group comparison was done by applying the Wilcoxon Matched Pairs test and comparisons between any two groups, and for pairwise comparisons, the Mann-Whitney U test was applied. Further, the Spearman rank order correlation was used to test the associations. 

Result

As compared to healthy subjects, RA patients exhibited significantly lowered CANO and CawNO with higher DawNO. 

Conclusion

A significant difference was between healthy and RA subjects about exhaled NO parameters. It is uncertain if this can be defined by the pathogenesis of RA, outcomes of long-term disease, and/or due to drug therapy.

Source:

Nitric Oxide

Article:

Altered levels of exhaled nitric oxide in rheumatoid arthritis

Authors:

AlexandraThornadtsson et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: